451 related articles for article (PubMed ID: 34857900)
21. Gut microbiota-derived metabolites and their importance in neurological disorders.
Swer NM; Venkidesh BS; Murali TS; Mumbrekar KD
Mol Biol Rep; 2023 Feb; 50(2):1663-1675. PubMed ID: 36399245
[TBL] [Abstract][Full Text] [Related]
22. Does the Gut Microbial Metabolome Really Matter? The Connection between GUT Metabolome and Neurological Disorders.
Marć MA; Jastrząb R; Mytych J
Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235622
[TBL] [Abstract][Full Text] [Related]
23. Healthy Gut, Healthy Brain: The Gut Microbiome in Neurodegenerative Disorders.
Chandra S; Alam MT; Dey J; Sasidharan BCP; Ray U; Srivastava AK; Gandhi S; Tripathi PP
Curr Top Med Chem; 2020; 20(13):1142-1153. PubMed ID: 32282304
[TBL] [Abstract][Full Text] [Related]
24. Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration.
Mahbub NU; Islam MM; Hong ST; Chung HJ
Front Cell Infect Microbiol; 2024; 14():1348279. PubMed ID: 38435303
[TBL] [Abstract][Full Text] [Related]
25. Gut Microbiota as a Mediator of Host Neuro-Immune Interactions: Implications in Neuroinflammatory Disorders.
Caputi V; Popov J; Giron MC; O Apos Mahony S
Mod Trends Psychiatry; 2021; 32():40-57. PubMed ID: 34032644
[TBL] [Abstract][Full Text] [Related]
26. The Role of Gut Microbiota and Gut-Brain Interplay in Selected Diseases of the Central Nervous System.
Doroszkiewicz J; Groblewska M; Mroczko B
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576191
[TBL] [Abstract][Full Text] [Related]
27. Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders.
Zheng Y; Bonfili L; Wei T; Eleuteri AM
Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960284
[TBL] [Abstract][Full Text] [Related]
28. Editorial: A Microbial View of Central Nervous System Disorders: Interplay Between Microorganisms, Neuroinflammation and Behaviour.
Cossu D; Watson RO; Farina C
Front Immunol; 2021; 12():816227. PubMed ID: 34975927
[No Abstract] [Full Text] [Related]
29. The Microbiota-Gut-Brain Axis as a Key to Neuropsychiatric Disorders: A Mini Review.
Stopińska K; Radziwoń-Zaleska M; Domitrz I
J Clin Med; 2021 Oct; 10(20):. PubMed ID: 34682763
[TBL] [Abstract][Full Text] [Related]
30. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease.
Goyal D; Ali SA; Singh RK
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110112. PubMed ID: 32949638
[TBL] [Abstract][Full Text] [Related]
31. Potential roles of gut microbiota and microbial metabolites in Parkinson's disease.
Zheng SY; Li HX; Xu RC; Miao WT; Dai MY; Ding ST; Liu HD
Ageing Res Rev; 2021 Aug; 69():101347. PubMed ID: 33905953
[TBL] [Abstract][Full Text] [Related]
32. Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.
Nagu P; Parashar A; Behl T; Mehta V
J Mol Neurosci; 2021 Jul; 71(7):1436-1455. PubMed ID: 33829390
[TBL] [Abstract][Full Text] [Related]
33. T
Choi J; Kim BR; Akuzum B; Chang L; Lee JY; Kwon HK
Front Immunol; 2022; 13():916066. PubMed ID: 35844606
[TBL] [Abstract][Full Text] [Related]
34. Deciphering the gut microbiome in neurodegenerative diseases and metagenomic approaches for characterization of gut microbes.
Singh N; Singh V; Rai SN; Mishra V; Vamanu E; Singh MP
Biomed Pharmacother; 2022 Dec; 156():113958. PubMed ID: 36411639
[TBL] [Abstract][Full Text] [Related]
35. The gut microbiota-brain axis in neurological disorder.
Ullah H; Arbab S; Tian Y; Liu CQ; Chen Y; Qijie L; Khan MIU; Hassan IU; Li K
Front Neurosci; 2023; 17():1225875. PubMed ID: 37600019
[TBL] [Abstract][Full Text] [Related]
36. Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders.
Chen Y; Xu J; Chen Y
Nutrients; 2021 Jun; 13(6):. PubMed ID: 34205336
[TBL] [Abstract][Full Text] [Related]
37. Multi-omic analysis of host-microbial interactions central to the gut-brain axis.
Simpson JB; Redinbo MR
Mol Omics; 2022 Dec; 18(10):896-907. PubMed ID: 36169030
[TBL] [Abstract][Full Text] [Related]
38. Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson's Disease.
Kaur G; Behl T; Bungau S; Kumar A; Uddin MS; Mehta V; Zengin G; Mathew B; Shah MA; Arora S
Curr Neuropharmacol; 2021; 19(2):233-247. PubMed ID: 32504503
[TBL] [Abstract][Full Text] [Related]
39. Gut-Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders.
Toledo ARL; Monroy GR; Salazar FE; Lee JY; Jain S; Yadav H; Borlongan CV
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163103
[TBL] [Abstract][Full Text] [Related]
40. Unravelling the potential of gut microbiota in sustaining brain health and their current prospective towards development of neurotherapeutics.
Banerjee A; Pradhan LK; Sahoo PK; Jena KK; Chauhan NR; Chauhan S; Das SK
Arch Microbiol; 2021 Aug; 203(6):2895-2910. PubMed ID: 33763767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
